Actively Recruiting

Age: 18Years - 75Years
All Genders
Healthy Volunteers
ID07617441

The Neuroanatomical and Psychological Correlates of Suggestibility in Patients With Non-Responsive Chronic Migraine

Led by Istituto per la Ricerca e l'Innovazione Biomedica · Updated on 2026-06-01

200

Participants Needed

1

Research Sites

43 weeks

Total Duration

On this page

Sponsors

I

Istituto per la Ricerca e l'Innovazione Biomedica

Lead Sponsor

A

Azienda Ospedaliera Universitaria Renato Dulbecco

Collaborating Sponsor

AI-Summary

What this Trial Is About

Chronic migraine is a disabling neurovascular disorder that often resists current treatments, leading researchers to explore new therapeutic approaches to lessen symptoms and improve quality of life. This study focuses on understanding the role of suggestibility, or how patients respond to expectations and contextual influences, in non-responsive chronic migraine (NRCM). It aims to identify neurobiological and psychological profiles that may predict which patients benefit from placebo effects. The study is observational and plans to recruit at least 100 patients with NRCM and 100 healthy control subjects matched by age and sex. It will use advanced magnetic resonance imaging (connectomics) alongside a detailed set of psychological tests to assess suggestibility and other psychobiological traits. Participants are divided into two groups: those with non-responsive chronic migraine and healthy controls. Participants will undergo a single baseline assessment to measure suggestibility levels and undergo neuroimaging and psychodiagnostic evaluations. Researchers will compare profiles between individuals with high and low suggestibility to identify distinct bio-phenotypes. The study will monitor participants over the course of the trial, which runs until May 2029, to better understand placebo mechanisms and inform personalized treatments.

CONDITIONS

Brief Title

The Neuroanatomical and Psychological Correlates of Suggestibility in Patients With Non-Responsive Chronic Migraine

Who Can Participate

Age: 18Years - 75Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 to 75 years
  • Diagnosis of non-responsive chronic migraine (NRCM) according to ICHD-3 beta criteria
  • At least 8 migraine days per month causing disability (MIDAS 6 11)
  • Insufficient response or intolerance to at least three migraine preventive treatments for 6 weeks or more
  • Signed informed consent
  • Adults aged 18 to 75 years without NRCM or relevant neurological disorders for healthy subjects
  • Signed informed consent for healthy subjects
Not Eligible

You will not qualify if you...

  • Older than 75 years
  • Children
  • Pregnant or breastfeeding women
  • History of alcohol or substance abuse
  • Concomitant neurological, cardiovascular, or cerebrovascular diseases
  • Liver or kidney disease
  • Psychiatric disorders such as psychosis, major depression, bipolar disorder
  • Diagnosis or history of migraine for healthy subjects

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Single assessment at enrollment

Participants undergo assessments to measure suggestibility levels and neuroanatomical and psychological characteristics.

1 visit (in-person)

Long-term Monitoring

Duration - Up to approximately 1 year

Participants are observed over time to monitor suggestibility and migraine characteristics without active intervention.

Visits as scheduled per study protocol

Trial Site Locations

Total: 1 location

1

Renato Dulbecco University Hospital

Catanzaro, Catanzaro, Italy, 88100

Actively Recruiting

Loading map...

Research Team

D

Domenico Bosco, Medical Doctor

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

Clinical Study of Myofascial Trigger Points Injection for Ch...

Myofascial Trigger Points

Actively Recruiting

1 location

Molecular Phenotyping of Migraine Patients by Age and Sex Th...

Headache (Migraine)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here